Jasper Ridge Partners, L.P. Oric Pharmaceuticals, Inc. Transaction History
Jasper Ridge Partners, L.P.
- $3.15 Billion
- Q4 2024
A detailed history of Jasper Ridge Partners, L.P. transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Jasper Ridge Partners, L.P. holds 20,870 shares of ORIC stock, worth $131,481. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,870
Previous 20,870
-0.0%
Holding current value
$131,481
Previous $213,000
21.13%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding ORIC
# of Institutions
130Shares Held
67.1MCall Options Held
404KPut Options Held
6.4K-
Nextech Invest Ag5.29MShares$33.3 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$30.4 Million0.0% of portfolio
-
Viking Global Investors LP4.43MShares$27.9 Million0.12% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$27.7 Million5.85% of portfolio
-
Alkeon Capital Management LLC New York, NY3.9MShares$24.6 Million0.07% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $249M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...